^
No biomarker
Marginal Zone Lymphoma
zanubrutinib
Sensitive
:
A1
No biomarker
Marginal Zone Lymphoma
rituximab + lenalidomide
Sensitive
:
A1
No biomarker
Marginal Zone Lymphoma
umbralisib
Sensitive
:
A1
No biomarker
Marginal Zone Lymphoma
ibrutinib
Sensitive
:
A1
No biomarker
Marginal Zone Lymphoma
R-CVP
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
R-CHOP
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
rituximab
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
axicabtagene ciloleucel
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
obinutuzumab
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
idelalisib
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
duvelisib
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
copanlisib
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
cyclophosphamide
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
chlorambucil
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
ibritumomab tiuxetan
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
G-CHOP
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
lisocabtagene maraleucel
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
tisagenlecleucel-T
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
O-CVP
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
INCB50465
Sensitive
:
B
MYD88 mutation
Marginal Zone Lymphoma
ibrutinib
Sensitive
:
C3
CARD11 mutation
Marginal Zone Lymphoma
ibrutinib
Resistant
:
C3
KMT2D mutation
Marginal Zone Lymphoma
ibrutinib
Resistant
:
C3
MYD88 L265P
Marginal Zone Lymphoma
ibrutinib
Sensitive
:
C3
TNFAIP3 mutation
Marginal Zone Lymphoma
ibrutinib
Sensitive
:
C3
CD5 positive
Marginal Zone Lymphoma
rituximab
Resistant
:
C3
LDH elevation
Marginal Zone Lymphoma
ViPOR
Sensitive
:
C3
TNFAIP3 mutation
Marginal Zone Lymphoma
zanubrutinib
Sensitive
:
C3
MYD88 mutation
Marginal Zone Lymphoma
zanubrutinib
Sensitive
:
C3
TP53 mutation + MET amplification + PD-L1 overexpression
Marginal Zone Lymphoma
sintilimab
Sensitive
:
C4
NOTCH2 mutation + NCOA4 mutation + PTEN mutation + EPHA3 mutation + KMT2D mutation
Marginal Zone Lymphoma
rituximab
Sensitive
:
C4
BIRC3-MALT1 fusion
Marginal Zone Lymphoma
R-CHOP
Sensitive
:
C4